BioCryst Reports Third Quarter 2017 Financial Results

Go back to BioCryst Reports Third Quarter 2017 Financial Results
BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) Delayed: 8.80 +0.12 (1.38%)
Previous Close $8.68    52 Week High $10.98 
Open $8.75    52 Week Low $1.63 
Day High $8.85    P/E N/A 
Day Low $8.58    EPS $-0.68 
Volume 1,964,141